These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30348250)

  • 1. Application of in Silico Tools in Clinical Practice using Ketoconazole as a Model Drug.
    Silva DA; Duque MD; Davies NM; Löbenberg R; Ferraz HG
    J Pharm Pharm Sci; 2018; 21(1s):242s-253s. PubMed ID: 30348250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole.
    Cristofoletti R; Patel N; Dressman JB
    J Pharm Sci; 2017 Feb; 106(2):560-569. PubMed ID: 27865610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization.
    Saxena A; Shah D; Padmanabhan S; Gautam SS; Chowan GS; Mandlekar S; Desikan S
    Eur J Pharm Sci; 2015 Aug; 76():173-80. PubMed ID: 25960252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole ion-exchange fiber complex: a novel method to reduce the individual difference of bioavailability in oral administration caused by gastric anacidity.
    Xin C; Li-hong W; Jing Y; Yang Y; Yue Y; Qi-fang W; San-ming L
    Pharm Dev Technol; 2013; 18(6):1346-54. PubMed ID: 22670853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
    Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
    J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    AAPS PharmSciTech; 2017 May; 18(4):1203-1212. PubMed ID: 27431914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study.
    Kuminek G; Salehi N; Waltz NM; Sperry DC; Greenwood DE; Hate SS; Amidon GE
    Mol Pharm; 2023 Jan; 20(1):147-158. PubMed ID: 36367432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
    Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
    Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir.
    Kambayashi A; Dressman JB
    J Pharm Sci; 2019 Jan; 108(1):584-591. PubMed ID: 30423339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling.
    Ruff A; Fiolka T; Kostewicz ES
    Eur J Pharm Sci; 2017 Mar; 100():42-55. PubMed ID: 28011125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of food components on the intrinsic dissolution rate of ketoconazole.
    Ghazal HS; Dyas AM; Ford JL; Hutcheon GA
    Drug Dev Ind Pharm; 2015; 41(10):1647-54. PubMed ID: 26288994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole.
    Chin TW; Loeb M; Fong IW
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1671-5. PubMed ID: 7486898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola
    Hens B; Bermejo M; Cristofoletti R; Amidon GE; Amidon GL
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32570975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.